Some in the White House believe that the additional dose would have helped somewhat with the rapidly spreading BA.5 subvariant, and also lift the confidence of anyone worried that their protection had waned. In recent weeks, some of those frustrations have bubbled up again, as regulators considered whether to recommend a fourth shot for all adults, not just those at highest risk from the virus. Privately, West Wing officials believe the delay cost lives, preventing optimum protection amid the Delta and Omicron surges, but also fed into doubts about vaccine and booster effectiveness that impacted their uptake. The White House has at times been frustrated by the pace of decision-making at the FDA and CDC, most notably last summer, when the regulators took weeks to decide whether to authorize the first booster dose for U.S. The government contracts include options to purchase 300 million doses each, but reaching that total will require more funding from Congress, the Biden administration said.Īs for timing, getting a booster too soon after the previous dose means missing out on its full benefit - something policymakers will have to take into consideration when rolling out revamped shots. But how soon large amounts would become available isn't clear. has a contract to buy 105 million doses of the Pfizer combination shots once they're ready, and 66 million of Moderna's version. The FDA and the Centers for Disease Control and Prevention would have to sign off on revamped shots before their launch. Anthony Fauci on state of the COVID-19 pandemic 04:34
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |